Crossmark

Comment on “CT-based intratumoral and peritumoral radiomics to predict the treatment response to hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 in high-risk hepatocellular carcinoma cases: a multi-center study”

Crossref DOI link: https://doi.org/10.1007/s12072-025-10912-5

Published Online: 2025-09-15

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shi, Zhiyao

Feng, Kai

Gao, Yu

Wang, Xixing https://orcid.org/0000-0003-2444-7248
Funding

Funding for this research was provided by:

State Administration of Traditional Chinese Medicine of the People's Republic of China (2022-245)

State Administration of Traditional Chinese Medicine of the People's Republic of China (202203)

State Administration of Traditional Chinese Medicine of the People's Republic of China (2018-131)

Department of Science and Technology of Shanxi Province (02103021224437)

Department of Science and Technology of Shanxi Province ([2019]61)

Health Commission of Shanxi Province (2020TD04)

Health Commission of Shanxi Province (2022XM10)
License Information

Text and Data Mining valid from 2025-09-15

Version of Record valid from 2025-09-15
More Information

Article History

Received: 4 August 2025

Accepted: 30 August 2025

First Online: 15 September 2025

Declarations

:

: The authors declare no conflicts of interest.

: The authors have nothing to report.

Document is current

Any future updates will be listed below